Acetylcysteine/Mesalazine
乙酰半胱氨酸/美沙拉嗪
Report date: 2022/07/04 19:38:02
Base Information
Drug NameAcetylcysteine/Mesalazine
Drug Alias Name +[14]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes AcetylcysteineMesalazine
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oklahoma Health Sciences CenterAltheus Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAltheus Therapeutics Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A